首页|肺腺癌组织中FNDC1、Napsin A、Smad4表达及临床意义

肺腺癌组织中FNDC1、Napsin A、Smad4表达及临床意义

扫码查看
目的 检测肺腺癌中Ⅲ型纤连蛋白结构域 1(FNDC1)、天冬氨酸肽酶 A(Napsin A)、Smad4 的表达及其临床意义.方法 回顾性分析 2019 年 12 月至 2021 年 12 月华中科技大学同济医学院附属协和医院收治的 120 例肺腺癌患者临床病例资料,收集患者手术切除肿瘤组织和癌旁正常组织.采用免疫组化染色SP法检测肺腺癌组织与癌旁组织中FNDC1、Napsin A、Smad4 表达情况,并分析FNDC1、Napsin A、Smad4 表达与肺腺癌临床病理特征的关系.随访患者的生存情况,采用Kaplan-meier法绘制生存曲线,生存差异行Log-rank检验;采用Cox风险比例回归模型分析影响肺腺癌患者预后的因素.结果 肺腺癌组织中 FNDC1 阳性表达率为 61.67%,高于癌旁组织的 20.0%;Napsin A、Smad4 阳性表达率分别为 41.67%和65.0%,低于癌旁组织的 98.33%和 90.83%,差异均有统计学意义(P<0.05).FNDC1、Napsin A、Smad4 表达与性别、年龄无关(P>0.05),与TNM分期、病理学分级、肿瘤最大直径、淋巴结转移均有关(P<0.05).FNDC1 阴性表达组患者中位生存时间(OS)为 34 个月,优于阳性表达组的 27 个月;Napsin A、Smad4 阳性表达组患者中位生存时间分别为 30 个月和 30 个月,优于阴性表达组的 27 个月和 25 个月;差异均有统计学意义(P<0.05).单因素Cox风险比例回归模型显示,TNM分期、肿瘤最大直径、淋巴结转移、FNDC1 表达、NapsinA表达、Smad4 表达是影响肺腺癌OS的因素(P<0.05).结论 肺腺癌组织中FNDC1表达升高,Napsin A、Smad4 表达降低,且FNDC1、Napsin A、Smad4 表达与临床病理特征、总生存均有关.
The expression and clinical significance of FNDC1,Napsin A,and Smad4 in lung adenocarcinoma tissue
Objective To detect the expression and clinical significance of type Ⅲ fibronectin domain 1(FNDC1),aspartate peptidase A(Napsin A),and Smad4 in lung adenocarcinoma.Methods A retrospective analysis was conducted on the clinical data of 120 patients with lung adenocarcinoma admitted to our hospital from December 2019 to December 2021.Surgical resection of cancer tissue and adjacent normal tissue were collected from the patients.Immunohistochemical SP method was used to detect the expression of FNDC1,Napsin A,and Smad4 in lung adenocarcinoma tissues and adjacent tissues,and the relationship between the expression of FNDC1,Napsin A,and Smad4 and the clinical and pathological characteristics of lung adenocarcinoma was analyzed.The patient's survival status was followed up.Survival curve was drawn by Kaplan-meier method,and survival difference was tested by Log-rank test.Cox proportional regression model was used to analyze the prognostic factors of lung adenocarcinoma patients.Results The positive expression rate of FNDC1 in lung adenocarcinoma tissue was 61.67%,higher than 20.0%in adjacent tissues;The positive expression rates of Napsin A and Smad4 were 41.67%and 65.0%,respectively,which were lower than 98.33%and 90.83%in adjacent tissues,and the differences were statistically significant(P<0.05).The expression of FNDC1,Napsin A,and Smad4 was not related to gender and age(P>0.05),but was correlated with TNM staging,pathological grading,maximum tumor diameter,and lymph node metastasis(P<0.05).The median survival time(OS)of the FNDC1 negative expression group was 34 months,which was better than the 27 months of the positive expression group;The median survival time of the Napsin A and Smad4 positive expression groups was 30 months and 30 months,respectively,which was better than the 27 months and 25 months of the negative expression group;The differences were statistically significant(P<0.05).The univariate Cox risk proportional regression model showed that TNM staging,maximum tumor diameter,lymph node metastasis,FNDC1 expression,NapsinA expression,and Smad4 expression were factors affecting OS in lung adenocarcinoma(P<0.05).Conclusion The expression of FNDC1 is increased in lung adenocarcinoma tissue,while the expression of Napsin A and Smad4 is reduced.The expression of FNDC1,Napsin A,and Smad4 is related to clinical pathological characteristics and overall survival.

Lung adenocarcinomaType Ⅲ fibronectin domain 1Aspartate peptidase ASmad4Prognosis

江凌、杨彬、毛永忠

展开 >

430022 武汉 华中科技大学同济医学院附属协和医院综合科

430022 华中科技大学同济医学院附属协和医院全科医学科

430022 华中科技大学同济医学院附属协和医院外科

肺腺癌 Ⅲ型纤连蛋白结构域1 天冬氨酸肽酶A Smad4 预后

2024

临床肿瘤学杂志
解放军第八一医院

临床肿瘤学杂志

CSTPCD
影响因子:1.583
ISSN:1009-0460
年,卷(期):2024.29(3)
  • 15